S-cibenzoline (CT-G20) / Celltrion 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
S-cibenzoline (CT-G20) / Celltrion
NCT04418297: A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy

Terminated
1
23
Europe, US, RoW
CT-G20, Placebo
Celltrion
Cardiomyopathy, Hypertrophic Obstructive
11/22
11/22

Download Options